Last Updated: June 24, 2026

Amoxicillin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for amoxicillin and what is the scope of freedom to operate?

Amoxicillin is the generic ingredient in twenty-five branded drugs marketed by Aurobindo, Chartwell, Hikma Pharms, Labs Atral, Micro Labs, Mylan, Sandoz, Strides Pharma Intl, Sun Pharm Inds Ltd, Teva, Glaxosmithkline, Us Antibiotics, Apothecon, Parke Davis, Wyeth Ayerst, Aurobindo Pharma Ltd, Chartwell Rx, Hikma, Ph Health, Pragma, Ranbaxy Labs Ltd, Ani Pharms, Rising, Takeda Pharms Usa, Cumberland, Phathom, Aurobindo Pharma, Cipla, Deva Holding As, Micro Labs Ltd India, Sandoz Inc, Apotex Inc, Teva Pharms Usa, and Talicia Holdings, and is included in one hundred and twenty-six NDAs. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amoxicillin has eleven patent family members in six countries.

There are forty-six drug master file entries for amoxicillin. Forty suppliers are listed for this compound.

Drug Prices for amoxicillin

See drug prices for amoxicillin

Drug Sales Revenue Trends for amoxicillin

See drug sales revenues for amoxicillin

Recent Clinical Trials for amoxicillin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yueyue LiNA
Qilu Hospital of Shandong University, Dezhou BranchNA
Guanxian People's HospitalNA

See all amoxicillin clinical trials

Pharmacology for amoxicillin
Medical Subject Heading (MeSH) Categories for amoxicillin

US Patents and Regulatory Information for amoxicillin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd AMOXICILLIN AND CLAVULANATE POTASSIUM amoxicillin; clavulanate potassium TABLET;ORAL 091568-001 Jan 20, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Us Antibiotics AUGMENTIN '250' amoxicillin; clavulanate potassium TABLET, CHEWABLE;ORAL 050597-002 Jul 22, 1985 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Labs Atral AMOXICILLIN amoxicillin CAPSULE;ORAL 062528-001 Aug 7, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mylan AMOXICILLIN amoxicillin CAPSULE;ORAL 062067-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Us Antibiotics AMOXIL amoxicillin FOR SUSPENSION;ORAL 062226-002 Approved Prior to Jan 1, 1982 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva AMOXICILLIN AND CLAVULANATE POTASSIUM amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 065089-002 May 25, 2004 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Inds Ltd AMOXICILLIN AND CLAVULANATE POTASSIUM amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 065132-002 Mar 19, 2003 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for amoxicillin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 6,544,555 ⤷  Start Trial
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 6,723,341 ⤷  Start Trial
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 6,669,948 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for amoxicillin

Country Patent Number Title Estimated Expiration
Australia 2006321782 Pharmaceutical compositions and methods for improved bacterial eradication ⤷  Start Trial
Australia 2006351475 Modified release amoxicillin products ⤷  Start Trial
Canada 2635378 COMPOSITIONS PHARMACEUTIQUES ET METHODES POUR ERADICATION BACTERIENNE AMELIOREE (PHARMACEUTICAL COMPOSITIONS AND METHODS FOR IMPROVED BACTERIAL ERADICATION) ⤷  Start Trial
Canada 2635606 PRODUITS D'AMOXICILLINE A LIBERATION MODIFIEE (MODIFIED RELEASE AMOXICILLIN PRODUCTS) ⤷  Start Trial
China 101563466 Modified release amoxicillin products ⤷  Start Trial
European Patent Office 1968586 COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES POUR ÉRADICATION BACTÉRIENNE AMÉLIORÉE (PHARMACEUTICAL COMPOSITIONS AND METHODS FOR IMPROVED BACTERIAL ERADICATION) ⤷  Start Trial
European Patent Office 1969134 PRODUITS D'AMOXICILLINE À LIBÉRATION MODIFIÉE (MODIFIED RELEASE AMOXICILLIN PRODUCTS) ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.